article thumbnail

Catasys Finds $45M In Debt Financing For Mental Health Efforts

socalTECH

The company said the financing consists of Senior Secured Notes due 2024 pursuant to a committed purchase of up to $45 million, comprised of a $35 million initial purchase and up to $10 million in additional issuances. The company--led by founder and CEO Terren Peizer--said the funding will go to support accelerating growth at the company.

article thumbnail

Bio Roundup: Rare Disease Showdowns, Prices on TV, Dealmania & More

Xconomy

An April report from Evaluate Pharma predicted sales of orphan drugs to rise 12 percent a year between now and 2024, when they will account for an estimated 20 percent of worldwide prescription drug sales. The market for drugs for rare or “orphan” diseases continues to grow.

Pricing 97
article thumbnail

Bio Roundup: Drug Price Debates, NY Bio Blooms & CEOs Take Social Stand

Xconomy

If you missed it, you’ll have to wait until 2024 for the next one. In these politically divided times, Americans this week found near universal agreement on one thing: A celestial event that plunges a summer day into temporary darkness is a captivating experience. The totality of the solar eclipse lasted less than 3 minutes.

Pricing 49